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With the threat of a new influenza pandemic that
may develop as a result of the ongoing and
uncontrolled panzootic of H5N1 bird influenza,
emerging infections have never been so high on
the public health and political agenda in western
countries, Europe in particular. Although there is
a strong tendency to assume that the next serious
emerging infectious diseases will be caused by an
RNA virus that ‘jumped through’ mutations or
progressive adaptation from an animal reservoir
to humans where it will spread and cause disease,
there are other scenarios of emergence that
western and European countries should consider.
The emergence of the new hypervirulent Clostrid-
ium difficile PCR ribotype 027 in hospitals in
Canada and the USA in 2003, and its secondary
diffusion to hospitals in several European coun-
tries, including the UK, the Netherlands, Belgium
and France, perfectly illustrates the diversity
among modes of emerging infectious diseases.
The free movement of European citizens, includ-
ing patients moving from hospitals of one country
to another, creates the potential for further spread
of this hyper-virulent and multidrug resistant
bacteria among vulnerable patients in European
hospitals. The threat of the C. difficile PCR ribo-
type O27 will remain an issue of major public
health relevance in Europe for years to come, and
is further compounded by the fact that laboratory
detection, surveillance, control and prevention
strategies concerning C. difficile infections in the
hospital setting are highly variable within the
European Union. Late recognition could thus
delay appropriate responses and delay mobilisa-
tion of the necessary resources. A coordinated
European approach is therefore necessary.
Awareness, preparedness, capacity for detection,
ongoing surveillance and timely response are the
key issues in controlling emerging infections.
Following these principles, and according to its
legal mandate, the newly established European
Centre for Disease Prevention and Control
(ECDC) convened a group of experts comprised
of microbiologists, infection control specialists
and epidemiologists to assess the threat and to
propose further steps to be undertaken at the
European level. One of the outcomes of this
initiative is a comprehensive review of the current
knowledge, of the existing prevention and control
strategies and of the challenges posed by the
C. difficile PCR ribotype O27 which Clinical Micro-
biology and Infection is publishing as this special
supplementary issue. The publication of this
experts’ report illustrates the contribution of
CMI, in partnership with European institutions
such as the ECDC, to preparedness against
emerging infectious threats by increasing the
awareness of the clinicians, infection control
specialists and clinical microbiologists among its
readership and beyond.
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